Anixa Biosciences's total assets for Q2 2025 were $16.98M, a decrease of -10.20% from the previous quarter. ANIX total liabilities were $2.07M for the fiscal quarter, a -5.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.